A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects - Concepedia

Concepedia

Publication | Open Access

A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects

DOI Full Paper Access

54

Citations

23

References

2015

Year

Inge Lues, Frank Weber, Antje Meyer, Uli Bühring, Torsten Hoffmann, Kerstin Kühn‐Wache, Susanne Manhart, Ulrich Heiser, Rolf Pokorny, Joseph Chiesa,

Alzheimer s & Dementia Translational Research & Clinical Interventions

Abstract

This first-in-man study of a compound-targeting QC inhibition justifies further development of PQ912 for the treatment of AD.

References

	Year	Citations

Page 1